145 related articles for article (PubMed ID: 27379567)
1. Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis.
Hedayatfar A; Falavarjani KG; Soheilian M; Elmi Sadr N; Modarres M; Parvaresh MM; Naseripour M; Rohani M; Almasi M; Chee SP
Ocul Immunol Inflamm; 2017 Jun; 25(3):308-314. PubMed ID: 27379567
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
[TBL] [Abstract][Full Text] [Related]
4. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil in the treatment of uveitis in children.
Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
[TBL] [Abstract][Full Text] [Related]
6. Clinical findings and outcomes of uveitis associated with multiple sclerosis.
AlBloushi AF; Dheyab AM; Al-Swaina NF; Al-Obailan M; Daif AK; Abu El-Asrar AM
Eur J Ophthalmol; 2021 Mar; 31(2):482-490. PubMed ID: 32019337
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
Lau CH; Comer M; Lightman S
Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
Bhat P; Cervantes-Castañeda RA; Doctor PP; Anzaar F; Foster CS
Ocul Immunol Inflamm; 2009; 17(3):185-90. PubMed ID: 19585361
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Mycophenolate Mofetil in the Treatment of Recalcitrant Intermediate Uveitis.
Ali S; Kharel Sitaula R; Biswas J
Ocul Immunol Inflamm; 2019; 27(5):851-857. PubMed ID: 29652198
[No Abstract] [Full Text] [Related]
11. Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
Jouve L; Benrabah R; Héron E; Bodaghi B; Le Hoang P; Touitou V
Ocul Immunol Inflamm; 2017 Jun; 25(3):302-307. PubMed ID: 26902594
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil as an immunomodulator in refractory noninfectious uveitis.
Rodriguez EE; Sakata VM; Cavalcanti DC; Zaghetto JM; Olivalves E; Hirata CE; Yamamoto JH
Arq Bras Oftalmol; 2016; 79(6):369-372. PubMed ID: 28076562
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in the therapy of uveitic macular edema--long-term results.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Ocul Immunol Inflamm; 2012 Jun; 20(3):203-11. PubMed ID: 22489750
[TBL] [Abstract][Full Text] [Related]
14. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
Sobrin L; Christen W; Foster CS
Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
[TBL] [Abstract][Full Text] [Related]
16. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
Gangaputra SS; Newcomb CW; Joffe MM; Dreger K; Begum H; Artornsombudh P; Pujari SS; Daniel E; Sen HN; Suhler EB; Thorne JE; Bhatt NP; Foster CS; Jabs DA; Nussenblatt RB; Rosenbaum JT; Levy-Clarke GA; Kempen JH;
Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
Rathinam SR; Babu M; Thundikandy R; Kanakath A; Nardone N; Esterberg E; Lee SM; Enanoria WT; Porco TC; Browne EN; Weinrib R; Acharya NR
Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273
[TBL] [Abstract][Full Text] [Related]
18. Ranibizumab for refractory uveitis-related macular edema.
Acharya NR; Hong KC; Lee SM
Am J Ophthalmol; 2009 Aug; 148(2):303-309.e2. PubMed ID: 19427988
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
Tsui E; Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Balamurugan S; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan J; Ebert CD; Kim E; Madow B; Porco TC; Acharya NR;
Ophthalmology; 2022 Jun; 129(6):661-667. PubMed ID: 35143800
[TBL] [Abstract][Full Text] [Related]
20. Visual outcomes of pars plana vitrectomy with epiretinal membrane peel in patients with uveitis.
Tanawade RG; Tsierkezou L; Bindra MS; Patton NA; Jones NP
Retina; 2015 Apr; 35(4):736-41. PubMed ID: 25462433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
